Abbott adds Laralab AI-based cardiac imaging tech
October 9, 2025
An Abbott (NYSE: ABT)+
official took to social media today to share that the company added Laralab to its portfolio of digital offerings.
An Abbott (NYSE: ABT)+
official took to social media today to share that the company added Laralab to its portfolio of digital offerings.
ST. LOUIS, Oct. 9, 2025 /PRNewswire/ — Amplifi Vascular, developer of the first-of-its-kind Vein Dilation System designed to increase eligibility, improve creation and early maturation of arteriovenous fistulas (AVFs) for hemodialysis, today announced three major milestones: positive first-in-human (FIH) study results, the close of a $6.9 million Series A financing, and U.S. Food and Drug Administration (FDA) approval of its Investigational Device Exemption (IDE).
JERSEY CITY, N.J. and OR YEHUDA, Israel, Oct. 8, 2025 /PRNewswire/ — Synchrony Medical, a medical technology company dedicated to transforming respiratory care, announced today the launch of its LibAirty™ Airway Clearance System in the United States. The launch marks an important step forward for people living with chronic lung disease, providing access to advanced at-home therapy designed to improve daily breathing, reduce exacerbations and hospitalizations, and enhance quality of life.
MedTech Innovator held its Grand Prize Finals at AdvaMed’s the MedTech Conference, with Armor Medical coming away the winner.
Medtronic (NYSE: MDT)+
today announced the full U.S. rollout of the Neuroguard IEP system, a carotid stent and embolic protection device.
Medtronic (NYSE: MDT)+
announced today that it kicked off the European launch of its VitalFlow one-system ECMO solution.
Early Commercial Launch Demonstrates Strong Physician Demand, Successful Pre-Authorisations, and Widespread Payor Coverage
Olympus announced today that it has launched its SecureFlex single-use fine needle biopsy device in Europe and Japan.
Medical Microinstruments Inc. (MMI) says its robotics system has been used for the first microsurgical intracranial brain surgeries.
Plexāā announced that it launched its Bloom43 wearable preconditioning medical device for breast surgery in the U.S.